Xiaobin Lv
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 2
- Advanced biosensing and bioanalysis techniques 1
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 1
- Co-authors
- Yi Sang (3 shared papers)Chun Cheng (2 shared papers)Lei Zeng (2 shared papers)Jianjun Tang (2 shared papers)Yanqing Wu (3 shared papers)Qiannan Guo (3 shared papers)Yinghua Zhu (3 shared papers)Junjun Chu (3 shared papers)
- Journals
- Oncotarget (2 papers)Scientific Reports (1 paper)Oncology Reports (1 paper)Cancer Cell International (1 paper)Sensors and Actuators B Chemical (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaobin Lv
10 papers receiving 451 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 237
- Geriatrics and Gerontology 21
- Molecular Biology 363
- Oncology 61
- Immunology 42
Countries citing papers authored by Xiaobin Lv
This map shows the geographic impact of Xiaobin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Lv more than expected).
Fields of papers citing papers by Xiaobin Lv
This network shows the impact of papers produced by Xiaobin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Lv. The network helps show where Xiaobin Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 116 | |
| 2 | 2015 | 78 | |
| 3 | 2015 | 72 | |
| 4 | 2016 | 46 | |
| 5 | 2011 | 45 | |
| 6 | 2018 | 41 | |
| 7 | 2015 | 19 | |
| 8 | 2017 | 15 | |
| 9 | 2022 | 13 | |
| 10 | 2023 | 11 | |
| 11 | 2025 | 0 |
About Xiaobin Lv
Xiaobin Lv is a scholar working on Molecular Biology, Cancer Research, Oncology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 11 papers that have together received 456 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related molecular mechanisms research (2 papers), Ubiquitin and proteasome pathways (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (237 citations), Geriatrics and Gerontology (21 citations), Molecular Biology (363 citations), Oncology (61 citations) and Immunology (42 citations). Xiaobin Lv has collaborated with scholars based in China and United States. Frequent co-authors include Yi Sang, Chun Cheng, Lei Zeng, Jianjun Tang, Yanqing Wu, Qiannan Guo, Yinghua Zhu, Junjun Chu, Kaishun Hu and Bentong Yu. Their work appears in journals such as Oncotarget, Scientific Reports, Oncology Reports, Cancer Cell International and Sensors and Actuators B Chemical.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.